Cholangitis
MONDO:0004789An acute or chronic inflammatory process affecting the biliary tract.
Also known as: biliary tract infection, biliary tree inflammation, cholangitis, inflammation of biliary tree
142 clinical trials for this condition and its sub-types, 17 tagged with Cholangitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cholangitis
-
Cholecystitis 35 trials · 65 incl. sub-types
4 sub-types
- Acute cholecystitis 35 trials
- Acalculous cholecystitis 0 trials
- Emphysematous cholecystitis 0 trials
- Xanthogranulomatous cholecystitis 0 trials
-
Sclerosing cholangitis 3 trials · 57 incl. sub-types
5 sub-types
- Primary sclerosing cholangitis 54 trials Sub-types →
- Secondary sclerosing cholangitis 2 trials
- IgG4-related sclerosing cholangitis 0 trials
- Isolated neonatal sclerosing cholangitis 0 trials
- Neonatal ichthyosis-sclerosing cholangitis syndrome 0 trials
-
Acute cholangitis 7 trials · 42 incl. sub-types
1 sub-type
- Acute cholecystitis 35 trials
-
Autoimmune cholangitis 1 trial
-
Ascending cholangitis 0 trials
-
Chronic cholangitis 0 trials
-
Pericholangitis 0 trials
-
Suppurative cholangitis 0 trials
Most studied deeper sub-types
-
New drug A3907 tested for rare liver disease, study halted early
Disease control Stopped earlyThis study tested a drug called A3907 in 18 adults with Primary Sclerosing Cholangitis (PSC), a rare liver disease. The goal was to check if the drug is safe and how the body processes it. The study was stopped early, so results are limited.
Phase 2 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Antibiotic vancomycin tested as PSC treatment – trial stopped early
Disease control Stopped earlyThis study tested whether the antibiotic vancomycin, taken by mouth, is safe and effective for adults with primary sclerosing cholangitis (PSC), a rare liver disease. About 102 participants were randomly assigned to receive vancomycin or a placebo. The main goal was to see if van…
Phase 2/3 • Sponsor: Elizabeth Carey • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood test may tame the tightrope walk of transplant drugs
Diagnosis Stopped earlyThis study tests whether a blood test called TruGraf can help doctors fine-tune immunosuppression medications in liver transplant recipients with autoimmune liver diseases like autoimmune hepatitis, primary sclerosing cholangitis, or primary biliary cirrhosis. The test measures g…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC